high-throughput screening

Researchers used CRISPR-Cas9 screening assays in mouse and human cells to track down point mutations in the PARP1 gene that boost resistance to PARP inhibitor drugs.

Using a synthetic genetic screen, investigators identified potential drug targets and tumor suppressors in colorectal cancer xenograft models.

The gene-gene interactions research could lead to new therapies targeting cells with particular mutations, or combinations of targeted therapies.

Using two guide RNAs to excise chunks of the genome, an international team identified lncRNAs essential and inhibitory to human cancer cell line proliferation.

A team of Austrian scientists used their new screening method to investigate genes and transcription factors regulating T cell receptor signaling.